James M Malone, MD
Hematology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 5
- 2 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
5 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Malone’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
5 of 5 plans
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A64765 · Current
Licensed to practise in California · since 1998 · expires 2028-02-29 · University of Nebraska College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$15,233
Medicare paid this office $15,233 for 98 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 35 | $4,730 | $71 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $3,291 | $106 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $2,911 | $112 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 26 | $1,448 | $44 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $877 | $73 |
See all 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 35 | $4,730 | $71 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $3,291 | $106 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $2,911 | $112 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 26 | $1,448 | $44 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $877 | $73 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 20 | $631 | $32 |
Who their Medicare patients are
98 Original Medicare patients in 2024. Average age 72 · Women 48% · Also on Medicaid 33% · Health risk score 2.58. Above the middle of the specialty; the typical hematology clinician is at 2.35.
Conditions among them: High blood pressure 75% · Coronary heart disease 51% · Chronic kidney disease 48% · Heart failure 47% · Atrial fibrillation 44% · Diabetes 40% · COPD 33% · Depression 24% · Stroke 24% · Cancer 22% · Dementia 18%.
The office billed $65,248, Medicare allowed $19,252 and paid $15,233; for 198 services of 10 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 98 | 198 | 72 | 2.58 | $65,248 | $15,233 |
| 2023 | 69 | 133 | 72 | 2.25 | $38,563 | $8,901 |
| 2022 | 83 | 151 | 73 | 2.72 | $42,098 | $10,379 |
| 2021 | 84 | 125 | 74 | 3.03 | $35,037 | $9,199 |
| 2020 | 28 | 63 | 74 | 2.33 | $12,981 | $5,164 |
| 2019 | 195 | 443 | 74 | 1.82 | $98,212 | $34,203 |
| 2018 | 279 | 669 | 75 | 1.79 | $145,547 | $48,000 |
| 2017 | 298 | 785 | 74 | 1.89 | $158,838 | $60,585 |
| 2016 | 294 | 845 | 74 | 1.74 | $116,731 | $63,259 |
| 2015 | 296 | 720 | 75 | 1.61 | $101,289 | $53,344 |
| 2014 | 343 | 802 | 75 | 1.72 | $114,012 | $55,270 |
| 2013 | 539 | 35,170 | 75 | 1.59 | $1,973,602 | $1,005,649 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $2,445 | $60 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 18 | $1,219 | $42 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 20 | $633 | $32 |
2022: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $3,290 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 19 | $2,238 | $93 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 19 | $859 | $33 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 13 | $431 | $33 |
2021: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $1,978 | $60 |
| Return visit (30+ min) | 14 | $1,458 | $91 |
| Short return visit (20+ min) | 18 | $1,113 | $62 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 16 | $654 | $34 |
2020: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,329 | $60 |
2019: 3 services
| Return visit (30+ min) | 109 | $17,879 | $81 |
| Long return visit (40+ min) | 38 | $8,360 | $111 |
| Short return visit (20+ min) | 98 | $5,192 | $47 |
2018: 4 services
| Return visit (30+ min) | 156 | $24,179 | $75 |
| Long return visit (40+ min) | 43 | $9,012 | $100 |
| Short return visit (20+ min) | 120 | $7,512 | $45 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,648 | $55 |
2017: 5 services
| Return visit (30+ min) | 142 | $24,521 | $84 |
| Short return visit (20+ min) | 169 | $14,444 | $53 |
| Long return visit (40+ min) | 45 | $11,209 | $113 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,791 | $164 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $1,992 | $59 |
2016: 4 services
| Return visit (30+ min) | 122 | $26,078 | $85 |
| Short return visit (20+ min) | 225 | $22,178 | $57 |
| Long return visit (40+ min) | 36 | $9,011 | $114 |
| New patient visit (30+ min) | 13 | $1,084 | $83 |
2015: 3 services
| Return visit (30+ min) | 151 | $28,138 | $82 |
| Short return visit (20+ min) | 199 | $15,798 | $54 |
| Long return visit (40+ min) | 32 | $7,046 | $114 |
2014: 3 services
| Return visit (30+ min) | 181 | $33,210 | $76 |
| Short return visit (20+ min) | 203 | $14,026 | $50 |
| Long return visit (40+ min) | 34 | $5,536 | $103 |
2013: 22 services
| Injection, rituximab, 100 mg | 22 | $226,338 | None |
| Return visit (30+ min) | 273 | $55,850 | $77 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 40 | $31,970 | None |
| Injection, zoledronic acid (zometa), 1 mg | 17 | $20,365 | None |
| Short return visit (20+ min) | 243 | $20,309 | $55 |
| Administration of chemotherapy into vein, 1 hour or less | 51 | $19,971 | $118 |
| Long return visit (40+ min) | 79 | $17,529 | $110 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 16 | $6,879 | $61 |
| New patient visit (45+ min) | 38 | $4,942 | $130 |
| Injection of drug or substance under skin or into muscle | 61 | $3,829 | $20 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 28 | $3,136 | $59 |
| New patient visit (60+ min) | 20 | $3,066 | $153 |
| New patient visit (30+ min) | 36 | $2,966 | $82 |
| Administration of chemotherapy into vein, each additional hour | 24 | $2,874 | $26 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 25 | $2,679 | $27 |
| Administration of additional new drug or substance into vein, 1 hour or less | 13 | $2,051 | $60 |
| Irrigation of implanted venous access drug delivery device | 30 | $1,474 | $18 |
| Injection of additional new drug or substance into vein | 26 | $1,272 | $19 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 17 | $274 | $15 |
| Injection, ondansetron hydrochloride, per 1 mg | 16 | $128 | None |
| Injection, diphenhydramine hcl, up to 50 mg | 20 | $30 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 13 | $19 | None |
Money from drug and device companies
$17 in 2025
| 2025 | 1 | 1 | None | $17 |
| 2024 | 1 | 1 | None | $29 |
| 2023 | 1 | 1 | None | $115 |
| 2022 | 2 | 2 | None | $29 |
| 2021 | 2 | 5 | None | $78 |
| 2020 | 1 | 1 | None | $15 |
| 2019 | 4 | 5 | $150 | $203 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novo Nordisk | Wegovy | $17 | 1 payment
|
See the published payment
| Novo Nordisk | Meals · 2025-06-25 | Wegovy | $17 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $29
| Medtronic | Synchromedii | $29 | 1 payment
|
2023: $115
| Abbvie | Qulipta | $115 | 1 payment
|
2022: $29
| Abbvie | Creon | $16 | 1 payment
|
| Array Biopharma | Braftovi | $13 | 1 payment
|
2021: $78
| Astellas Pharma US | Padcev | $52 | 4 payments
|
| Pharmacyclics LLC An AbbVie | Imbruvica | $26 | 1 payment
|
2020: $15
| Allergan | Ubrelvy | $15 | 1 payment
|
2019: $203
| Alexion Pharmaceuticals | Soliris | $150 | 1 payment
|
| Pfizer | Xalkori | $23 | 2 payments
|
| Gilead Sciences | None | $15 | 1 payment
|
| Janssen Biotech | Darzalex | $15 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 96.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1457343113
- Licence
- CA A64765California A64765: Current · expires 2028-02-29
- Trained
- University of Nebraska College of Medicine, 1995
- Group
- Stanford Health Care
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A647650
- Taxonomy
- Federal specialty code 207RH0000X (207RH0000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2005-08-18
- NPI last updated
- 2024-04-12
- NPI record certified
- 2024-04-12
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 715 Tank Farm Rd Ste C, San Luis Obispo, CA, 93401 · 715 Tank Farm Road, San Luis Obispo, CA, 93401